PASEMNOGENE GLEPARVOVEC
UNII 2Q4YZ4G35L

Substance Identification & Data

This profile provides standardized clinical and technical data for Pasemnogene Gleparvovec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2Q4YZ4G35L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2913126-89-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

2Q4YZ4G35L

CAS Registry Number

2913126-89-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PASEMNOGENE GLEPARVOVEC

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C211721

National Cancer Institute reference terminology for clinical and research data.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pasemnogene Gleparvovec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PASEMNOGENE GLEPARVOVEC

Common Names & Synonyms

CAPSOMERE, RECOMBINANT ADENO-ASSOCIATED VIRUS 9 VIRAL CAPSID PROTEIN VP1 (422-TRYPTOPHAN,446-PHENYLALANINE) COMPLEX WITH VIRAL CAPSID PROTEIN VP2 (285-TRYPTOPHAN,309-PHENYLALANINE) COMPLEX WITH VIRAL CAPSID PROTEIN VP3 (220-TRYPTOPHAN,244-PHENYLALANINE) DECAMER, HEXACONTAMER, COMPLEX WITH DNA (RECOMBINANT ADENO-ASSOCIATED VIRUS VECTOR PAAV-SMN1-GENEBEAM V2020-03-11 CYTOMEGALOVIRUS ENHANCER REGION PLUS CYTOMEGALOVIRUS PROMOTER REGION PLUS HUMAN .BETA.-GLOBIN GENE INTRON FRAGMENT PLUS HUMAN SURVIVAL OF MOTOR NEURON PROTEIN SMN1 CODON-OPTIMIZED GENE PLUS HUMAN SOMATOTROPIN GENE POLYADENYLATION SIGNAL PLUS ADENO-ASSOCIATED VIRUS 2 INVERTED TERMINAL REPEAT FLANKS) (1:1)

PASEMNOGENE GLEPARVOVEC [INN]

RECOMBINANT NON-REPLICATING ADENO-ASSOCIATED VIRUS SEROTYPE 9 (AAV9) VECTOR, ENCODING A CODON-OPTIMISED HUMAN SURVIVAL OF MOTOR NEURON 1 (SMN1) GENE, UNDER CONTROL OF THE CYTOMEGALOVIRUS (CMV) ENHANCER/PROMOTER AND TERMINATED BY A HUMAN GROWTH HORMONE POLYADENYLATION SIGNAL, FLANKED BY AAV2 INVERTED TERMINAL REPEATS. A HUMAN BETA-GLOBIN INTRON HAS BEEN INSERTED BETWEEN THE PROMOTER AND THE SMN1 CODING REGION. THE VIRUS VECTOR ALSO CONTAINS MUTATIONS IN THE VIRAL CAPSID PROTEIN VP1 (F422W AND Y446F)

External Clinical & Regulatory Resources

Previous UNII2Q4U5R8QBV

Next UNII2Q51FLS550